Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [1] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [3] Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Borel, Christian
    Jung, Alain C.
    Burgy, Mickael
    CANCERS, 2020, 12 (09) : 1 - 19
  • [4] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [5] Neoadjuvant immunotherapy for head and neck squamous cell carcinoma
    Kuerten, Cornelius H. L.
    Ferris, Robert L.
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 : S167 - S187
  • [6] Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
    Llop, Sandra
    Plana, Maria
    Tous, Sara
    Ferrando-Diez, Angelica
    Brenes, Jesus
    Juarez, Marc
    Vidales, Zara
    Vilajosana, Esther
    Linares, Isabel
    Arribas, Lorena
    Duch, Maria
    Fulla, Marta
    Brunet, Aina
    Lozano, Alicia
    Cirauqui, Beatriz
    Mesia, Ricard
    Oliva, Marc
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] Allergic history and responses to immunotherapy in individuals with recurrent or metastatic head and neck squamous cell carcinoma
    Wang, Yannan
    Ma, Zhonghui
    Zheng, Qizhe
    Chu, Yinglin
    Hu, Yunshuang
    Liu, Fei
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [8] Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa
    Yang, Chuan-Chien
    Lien, Ching-Feng
    Hwang, Tzer-Zen
    Wang, Chih-Chun
    Wang, Chien-Chung
    Shih, Yu-Chen
    Yeh, Shyh-An
    Hsieh, Meng-Che
    CANCERS, 2022, 14 (10)
  • [9] The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck
    Scheff, Nicole N.
    Nilsen, Marci L.
    Li, Jinhong
    Harris, Alexandria L.
    Acharya, Rajesh
    Swartz, Andrew
    Hsieh, Ronan W.
    Anderson, Jennifer L.
    Ferris, Robert L.
    V. Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan P.
    ORAL ONCOLOGY, 2023, 140
  • [10] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
    Cohen, Ezra E. W.
    Bell, R. Bryan
    Bifulco, Carlo B.
    Burtness, Barbara
    Gillison, Maura L.
    Harrington, Kevin J.
    Quynh-Thu Le
    Lee, Nancy Y.
    Leidner, Rom
    Lewis, Rebecca L.
    Licitra, Lisa
    Mehanna, Hisham
    Mel, Loren K.
    Raben, Adam
    Sikora, Andrew G.
    Uppaluri, Ravindra
    Whitworth, Fernanda
    Zandberg, Dan P.
    Ferris, Robert L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345